Table 2.
Unadjusted Associations with FIT Completion over 2 Years in the STOP CRC Intervention Clinics
| OR | 95% CI | p | |
|---|---|---|---|
| Year in study | < 0.0001 | ||
| 1st | Ref | ||
| 2nd | 0.77 | 0.69–0.85 | |
| Age (years) | 0.0001 | ||
| ≤ 65 | Ref | ||
| > 65 | 1.42 | 1.19–1.69 | |
| Sex | 0.08 | ||
| Male | Ref | ||
| Female | 1.12 | 0.99–1.28 | |
| BMI (kg/m2) | 0.30 | ||
| < 18.5 | 0.80 | 0.44–1.46 | |
| 18.5–24.9 | Ref | ||
| 25.0–29.9 | 1.04 | 0.86–1.25 | |
| ≥ 30 | 0.90 | 0.76–1.08 | |
| Race | < 0.0001 | ||
| White | Ref | ||
| Asian | 3.04 | 2.37–3.90 | |
| Other | 0.91 | 0.70–1.17 | |
| Hispanic | 0.004 | ||
| No | Ref | ||
| Yes | 1.32 | 1.09–1.60 | |
| Primary language | < 0.0001 | ||
| English | Ref | ||
| Spanish | 1.85 | 1.50–2.29 | |
| Other | 2.60 | 2.09–3.24 | |
| Tobacco use | < 0.0001 | ||
| Current | Ref | ||
| Never | 1.99 | 1.69–2.33 | |
| Former | 1.68 | 1.39–2.02 | |
| Comorbidities | |||
| Diabetes | 1.19 | 1.03–1.38 | 0.02 |
| Depression | 0.85 | 0.73–0.99 | 0.04 |
| Chronic pulmonary disease | 0.82 | 0.70–0.96 | 0.02 |
| Charlson index | 0.71 | ||
| 0–2 | Ref | ||
| ≥ 3 | 0.96 | 0.75–1.22 | |
| Preventive care | |||
| FIT prior to study | < 0.0001 | ||
| No | Ref | ||
| Yes | 3.00 | 2.58–3.47 | |
| Flu vaccine in the past year | < 0.0001 | ||
| No | Ref | ||
| Yes | 1.35 | 1.17–1.55 | |
| Pap in the past 3 years (among women ≤ 65) | 0.001 | ||
| No | Ref | ||
| Yes | 1.38 | 1.14–1.67 | |
| Mammogram in past 2 years (among women) | < 0.0001 | ||
| No | Ref | ||
| Yes | 1.99 | 1.66–2.40 | |
| Residential city size (inhabitants) | 0.05 | ||
| < 10,000 | Ref | ||
| 10–50,000 | 0.89 | 0.72–1.10 | |
| > 50,000 | 0.67 | 0.49–0.93 | |
OR, odds ratio; CI, confidence interval; BMI, body mass index; FIT, fecal immunochemical test
All models account for clustering of patients within clinic and of year of follow-up within patient
Primary language was unknown for two patients